20 Jul McKesson
Joe DePinto, Head of Cell, Gene and Advanced Therapies
Oct. 10 | 4:15pm | Rentschler ATMP Ballroom
Irving, TX
(NASDAQ: MCK)
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Our Cell, Gene, and Advanced Therapies platform offers best-in-class capabilities to meet the unique needs associated with bringing these innovative products to market. Our solutions span the continuum of care innovation and delivery — from early clinical development, pre-launch planning, to commercialization — and provide an integrated approach toward addressing the pain points encountered by biopharma, providers, and payers. Informed by nearly a decade of experience within the space, this ecosystem of clinical, distribution, market access, technology, and data science capabilities offers an unmatched combination of expertise that has been designed to accelerate and enhance clinical and commercial outcomes for innovators operating within the market today.
